• GLP-1 (9-36) amide: Precision Antagonist for GLP-1R Signalin

  2026-07-28

  GLP-1 (9-36) amide provides researchers with a selective tool for dissecting glucagon-like peptide-1 receptor pathways, advancing metabolic regulation and type 2 diabetes studies. This guide covers experimental workflows, practical troubleshooting, and the latest evidence on antagonist specificity for robust, reproducible results.

• Hexamethonium Bromide: Reliable Antagonist for Neuronal-Type

  2026-07-27

  This article provides an evidence-driven exploration of how Hexamethonium Bromide (SKU B1592) addresses key challenges in neuronal signaling pathway and autonomic nervous system studies. By integrating recent literature and validated performance data, it guides researchers in optimizing protocols and interpreting data with confidence. The discussion emphasizes workflow reliability, product quality, and best practices for reproducible results.

• Syringin (SKU N1347): Reliable Solutions for Cell Viability

  2026-07-27

  This article delivers a scenario-driven, evidence-based guide for integrating Syringin (SKU N1347) into cell viability, proliferation, and cytotoxicity assays. Drawing on recent data and validated protocols, we address real-world laboratory challenges—ranging from solubility and reproducibility to signaling pathway analysis—while benchmarking the product's reliability and purity. Biomedical researchers will find actionable insights and direct links to quality-verified Syringin resources.

• Magnetic Stimulation Targets GABRE to Reverse Schizophrenia

  2026-07-26

  This study demonstrates that selective magnetic stimulation of the left prelimbic cortex downregulates the GABAA receptor epsilon subunit (GABRE), reversing schizophrenia-like behaviors and synaptic deficits in mouse models. The mechanistic findings suggest GABRE as a precise and promising target for noninvasive neuromodulation in schizophrenia research.

• AZ505: Unraveling SMYD2 Inhibition for Advanced Epigenetic R

  2026-07-25

  Explore how AZ505, a potent SMYD2 inhibitor, advances epigenetic regulation research and cancer biology. This article provides new insights into its mechanism, selectivity, and translational impact, offering a deeper perspective beyond current literature.

• Verapamil HCl Targets TXNIP to Mitigate Osteoporosis Progres

  2026-07-24

  This study uncovers a novel role for Verapamil HCl, an L-type calcium channel blocker, in osteoporosis management via TXNIP pathway suppression. The research demonstrates that verapamil modulates bone remodeling by influencing key molecular axes in osteoclasts and osteoblasts, offering translational potential for postmenopausal osteoporosis intervention.

• Evaluating Drug Responses in Cancer: Insights from Advanced

  2026-07-24

  Schwartz's dissertation introduces a refined framework for distinguishing drug-induced cytostatic and cytotoxic effects in cancer research. By dissecting the interplay between cell cycle arrest and cell death, the work clarifies how in vitro metrics can be optimized for more accurate preclinical drug evaluation.

• Comparative In Vitro Activity of Aminoglycoside Antibiotics

  2026-07-23

  This study systematically evaluates the in vitro efficacy of sisomicin, a new aminoglycoside antibiotic, compared to established agents such as gentamicin and tobramycin against a diverse set of clinical isolates. Key findings reveal nuanced differences in antibacterial potency and resistance patterns, providing critical insights for antibiotic resistance research and experimental design.

• Broad-Spectrum Bivalent mRNA Vaccine RQ3025 Counters SARS-Co

  2026-07-23

  The referenced study presents RQ3025, a bivalent mRNA vaccine designed to address SARS-CoV-2 variant diversity by incorporating spike protein mutations common to multiple lineages. Preclinical results demonstrate enhanced neutralizing activity and a Th1-skewed immune response across animal models, informing strategies for next-generation COVID-19 vaccines.

• Veratridine in Translational Research: From Sodium Channel D

  2026-07-22

  A strategic exploration of Veratridine as a voltage-gated sodium channel opener, connecting mechanistic neuroscience, cancer biology, and the cutting edge of chamber-specific cardiomyocyte differentiation. This thought-leadership article integrates recent advances, including Saito et al.'s work on pluripotent stem cell-derived cardiomyocytes, with practical guidance for translational researchers and a clear view of Veratridine’s role in enabling next-generation experimental platforms.

• Fluorescent Immunoassays for Rapid Detection of Amatoxins &

  2026-07-22

  This study introduces a computationally guided strategy for designing haptens and monoclonal antibodies, enabling simultaneous and highly sensitive detection of lethal amatoxins and phallotoxins in mushrooms. The dual-target fluorescent immunochromatographic assay (DT-FICA) offers rapid, accurate on-site analysis, addressing critical gaps in mushroom poisoning prevention.

• Pomalidomide (CC-4047) for Hematological Malignancy Research

  2026-07-21

  Pomalidomide (CC-4047) empowers researchers to dissect cytokine modulation and tumor microenvironment dynamics in multiple myeloma models. This guide delivers actionable protocols, troubleshooting insights, and comparative advantages to optimize hematological malignancy research using APExBIO's rigorously validated product.

• Substance P: Tachykinin Neuropeptide for Pain and Inflammati

  2026-07-21

  Substance P enables reproducible pain transmission and immune response studies through its high purity, water solubility, and robust NK-1 receptor activation. This article details optimized workflows and troubleshooting strategies for using Substance P in neuroinflammation and bioaerosol research, translating bench insights into actionable, high-fidelity experiments.

• METTL16-SENP3-LTF Axis Regulates Ferroptosis in Hepatocellul

  2026-07-20

  Wang et al. uncover the METTL16-SENP3-LTF signaling axis as a key modulator of ferroptosis resistance in hepatocellular carcinoma (HCC), establishing a mechanistic link between m6A RNA modification, iron metabolism, and tumorigenesis. Their findings suggest that targeting this pathway could sensitize HCC cells to ferroptosis, offering a new angle for therapeutic intervention.

• Alpha-Ketoglutarate: Mechanisms, Evidence, and Protocols in

  2026-07-20

  Alpha-ketoglutarate (α-KGA) is a pivotal TCA cycle intermediate, linking carbon and nitrogen metabolism and modulating immune cell function. Recent evidence shows α-KGA accumulation shapes tumor-immune crosstalk and therapy resistance. This dossier provides mechanistic clarity, protocol guidance, and factual boundaries for α-KGA in metabolic reprogramming research.

453 records 10/31 page Previous Next First page 上5页 678910 下5页 Last page